Vitamin D and cancer

Authors

  • Alberto Muñoz Terol Spain

Keywords:

Vitamin D, cancer, gene expression

Abstract

Vitamin D, particularly its metabolite 1a, 25-dihydroxyvi- tamin D3 (1a,25(OH)2D3, calcitriol), is a main regulator of gene expression. 1a,25(OH)2D3 modulates the transcription rate of hundreds of genes and the activity of several enzymes and signalling pathways. A series of novel effects recently described make of 1a,25(OH)2D3 an attractive subject of study.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Carsten, C. and Campbell, M.J. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids, 78: 127-136, 2013.

Giovanucci E. Epidemiology of vitamin D and colorectal cancer. Anticancer Agents Med Chem, 13: 11- 19, 2013.

Deeb et al. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 7: 684-700, 2007.

Lazzeroni et al. Vitamin D supplementation and cancer: review of randomized controlled trials. Anti- cancer Agents Med Chem, 13: 118-125, 2013.

Pálmer et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E- cadherin and the inhibition of b-catenin signaling J Cell Biol, 154: 369-387, 2001.

Pereira et al. Vitamin D and colon cancer. Endocr-Rel Cancer, 19: R51-71, 2012.

Pálmer et al. The transcription factor SNAIL represses vitamin D receptor expression and responsive- ness in human colon cancer. Nat Med, 10: 917-919, 2004

Published

2013-10-20

How to Cite

Muñoz Terol , A. (2013). Vitamin D and cancer. Encuentros En La Biología, 6(144), 55–58. Retrieved from https://revistas.uma.es/index.php/enbio/article/view/18253